Merck & Co., Inc.

Q4 2024 13F Holdings Report, Stock Holdings

Signature - Title
Kelly E. W. Grez - Corporate Secretary
Location
Kenilworth, NJ
Holdings as of
December 31, 2024
Value $
$258M
Num holdings
13
Date filed
2/14/2025, 11:14 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MRNA, PSNL, KYMR, ALEC, and STRO.
Next filing
Q1 2025 - May 14, 2025
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
KELLY E. W. GREZ Corporate Secretary Rahway, New Jersey 2/14/2025

Other Included Managers (1):

Num Name Location File Number
1 Merck Sharp & Dohme Llc Whitehouse Station, NJ